Finance

Beta
Lists
301281:SHE
Shandong Keyuan Pharmaceutical Co Ltd
CNÂ¥46.43
+3.92%
(+1.75) 1D
Jun 12, 3:04:34 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301281...
Open
CNÂ¥45.40
High
CNÂ¥47.65
Low
CNÂ¥44.10
Mkt. cap
5.03B
Avg. vol.
4.24M
Volume
5.00M
Dividend
0.11%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Apr 30, 2024
P/E ratio
213.58
52-wk high
CNÂ¥53.99
52-wk low
CNÂ¥25.87
EPS
CNÂ¥0.22
Shares outstanding
108.29M
No. of employees
650
Open
CNÂ¥45.40
High
CNÂ¥47.65
Low
CNÂ¥44.10
Mkt. cap
5.03B
Avg. vol.
4.24M
Volume
5.00M
Dividend
0.11%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Apr 30, 2024
P/E ratio
213.58
52-wk high
CNÂ¥53.99
52-wk low
CNÂ¥25.87
EPS
CNÂ¥0.22
Shares outstanding
108.29M
No. of employees
650
News stories
From sources across the web
About Shandong Keyuan Pharmaceutical Co Ltd
CEO-
Employees650
FoundedDec 27, 2004
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
116.66M
74.82M
95.54M
161.30M
Cost of goods sold
51.81M
39.09M
56.86M
68.39M
Cost of revenue
51.81M
39.09M
56.86M
68.39M
Research and development expenses
9.46M
16.13M
6.86M
5.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
38.81M
28.69M
35.57M
52.40M
Operating expense
50.49M
40.99M
47.71M
60.30M
Total operating expenses
102.30M
80.08M
104.56M
128.70M
Operating income
14.36M
-5.25M
-9.02M
32.61M
Other non operating income
-40.04K
4.39M
-4.31M
-335.82K
EBT including unusual items
20.12M
-11.82M
-15.17M
32.69M
EBT excluding unusual items
18.08M
-566.63K
-11.60M
33.02M
Income tax expense
543.00K
-439.44K
-281.98K
2.16M
Effective tax rate
2.70%
3.72%
1.86%
6.60%
Other operating expenses
596.05K
-3.05M
4.13M
-1.44M
Net income
19.60M
-11.21M
-14.92M
30.07M
Net profit margin
16.80%
-14.99%
-15.61%
18.64%
Earnings per share
-
-
-
-
Interest and investment income
3.27M
814.75K
1.69M
805.04K
Interest expense
-14.88K
-
-
-59.45K
Net interest expenses
3.25M
814.75K
1.69M
745.59K
Depreciation and amortization charges
-
-
-
-
EBITDA
26.13M
5.57M
2.89M
44.52M
Gain or loss from assets sale
-
-
-303.64K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more